New drug vicadrostat put to the heart test in healthy volunteers
NCT ID NCT07513207
First seen Jun 25, 2026 · Last updated Jul 28, 2026 · Updated 6 times
Summary
This early-stage trial checks whether a single dose of vicadrostat changes heart rhythm in 45 healthy adults. Participants receive vicadrostat, placebo, and moxifloxacin (a known heart-rate-affecting drug) in random order. The goal is to see if vicadrostat is safe for the heart before testing it in patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vicadrostat
- What this could lead to
- If this study shows vicadrostat is safe for the heart, it could support further testing of the drug for other conditions.
- What could go wrong
- This is an early, small study in healthy people, not patients. It only checks heart safety, not whether the drug works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test